{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:58:56Z","timestamp":1762505936473},"reference-count":31,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.3892\/or.2012.1814","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T06:58:57Z","timestamp":1336978737000},"page":"487-493","source":"Crossref","is-referenced-by-count":26,"title":["Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)"],"prefix":"10.3892","volume":"28","author":[{"given":"SATOSHI","family":"YAMAGUCHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RYUICHIRO","family":"NISHIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NOBUO","family":"YAEGASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUSHIGE","family":"KIGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TORU","family":"SUGIYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TSUNEKAZU","family":"KITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KANEYUKI","family":"KUBUSHIRO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KATSUJI","family":"KOKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAMICHI","family":"HIURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KATSUMI","family":"MIZUTANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAICHIRO","family":"YAMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEN","family":"TAKIZAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"key20180107215713_b1-or-28-02-0487","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3892\/or_00000316","article-title":"Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study","volume":"21","author":"Yamamoto","year":"2009","journal-title":"Oncol Rep"},{"key":"key20180107215713_b2-or-28-02-0487","first-page":"1681","article-title":"A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer","volume":"18","author":"Takeuchi","year":"1991","journal-title":"Jpn J Cancer Chemother"},{"key":"key20180107215713_b3-or-28-02-0487","first-page":"202","article-title":"In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction","volume":"7","author":"Kanazawa","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107215713_b4-or-28-02-0487","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000012076","article-title":"Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer","volume":"58","author":"Sugiyama","year":"2000","journal-title":"Oncology"},{"key":"key20180107215713_b5-or-28-02-0487","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bjc.6690656","article-title":"Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer","volume":"81","author":"Sugiyama","year":"1999","journal-title":"Br J Cancer"},{"key":"key20180107215713_b6-or-28-02-0487","first-page":"1569","article-title":"A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer","volume":"20","author":"Raspagliesi","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107215713_b7-or-28-02-0487","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ygyno.2010.07.031","article-title":"Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer - irinotecan and platinum chemotherapy","volume":"119","author":"Matsumura","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107215713_b8-or-28-02-0487","first-page":"695","article-title":"Phase II study of 254-S (cis-diammine glycolate platinum) for gynecological cancer","volume":"19","author":"Kato","year":"1992","journal-title":"Jpn J Cancer Chemother"},{"key":"key20180107215713_b9-or-28-02-0487","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000072333","article-title":"Phase I study of combination chemotherapy using irinotecan hydrochloride and nedaplatin for advanced or recurrent cervical cancer","volume":"65","author":"Machida","year":"2003","journal-title":"Oncology"},{"key":"key20180107215713_b10-or-28-02-0487","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.bjc.6602076","article-title":"Phase I-II study of irinotecan plus nedaplatin with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer","volume":"91","author":"Tsuda","year":"2004","journal-title":"Br J Cancer"},{"issue":"Suppl 14","key":"key20180107215713_b11-or-28-02-0487","first-page":"abs. 5088","article-title":"Phase II study of combination chemotherapy using irinotecan and nedaplatin for patients with primary advanced or recurrent cervical cancer","volume":"22","author":"Ohwada","year":"2004","journal-title":"Proc ASCO: J Clin Oncol"},{"key":"key20180107215713_b12-or-28-02-0487","first-page":"23","article-title":"Chemotherapy with paclitaxel, ifosmide, and cisplatin for the treatment of squamous cell cervical cancer","volume":"27","author":"Zanetta","year":"2000","journal-title":"Semin Oncol"},{"key":"key20180107215713_b13-or-28-02-0487","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1525-1438.2003.13004.x","article-title":"Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (\u22654 cm) stage IB and IIA cervical carcinoma","volume":"13","author":"Haung","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107215713_b14-or-28-02-0487","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00280-001-0407-1","article-title":"Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin","volume":"49","author":"D\u2019Agostino","year":"2002","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107215713_b15-or-28-02-0487","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1525-1438.2003.t01-1-13198.x","article-title":"Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study","volume":"13","author":"Vagno","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107215713_b16-or-28-02-0487","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/annonc\/mdg333","article-title":"A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjyvant cisplatin chemoradiation","volume":"14","author":"Duenas-Gonzales","year":"2003","journal-title":"Ann Oncol"},{"key":"key20180107215713_b17-or-28-02-0487","first-page":"465abs. 1869","article-title":"Combination chemotherapy with iirunotecan (irinotecan) and mitomycin C (MMC) for advanced or recurrent squamous cell carcinoma of the cervix: Japanese Gynecologic Oncology Group (JGOG) study","volume":"22","author":"Umesaki","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"key20180107215713_b18-or-28-02-0487","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygyno.2006.04.019","article-title":"Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate-and high risk stage IB-IIA cervical cancer","volume":"103","author":"Takeshima","year":"2006","journal-title":"Gynecol Oncol"},{"key":"key20180107215713_b19-or-28-02-0487","volume-title":"NCCN Clinical Practice Guidelines in Oncology-Cervical Cancer-v2","year":"2006"},{"key":"key20180107215713_b20-or-28-02-0487","volume-title":"National Cancer Institute in the United States (web-site)","author":"Cervical Cancer Treatment (PDQ\u00ae), Health Professional Version","year":"2011"},{"key":"key20180107215713_b21-or-28-02-0487","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/gyno.1997.4812","article-title":"Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results","volume":"67","author":"Sardi","year":"1997","journal-title":"Gynecol Oncol"},{"key":"key20180107215713_b22-or-28-02-0487","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0959-8049(97)10029-6","article-title":"Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer","volume":"34","author":"Benedetti-Panici","year":"1998","journal-title":"Eur J Cancer"},{"key":"key20180107215713_b23-or-28-02-0487","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/JCO.2000.18.8.1740","article-title":"Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer","volume":"18","author":"Chang","year":"2000","journal-title":"J Clin Oncol"},{"key":"key20180107215713_b24-or-28-02-0487","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2005.04.172","article-title":"Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (studio neo-adjuvante portio) Italian Collaborative Study","volume":"23","author":"Buda","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107215713_b25-or-28-02-0487","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ctrv.2006.09.007","article-title":"Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis","volume":"33","author":"Tzioras","year":"2007","journal-title":"Cancer Treat Rev"},{"issue":"S18","key":"key20180107215713_b26-or-28-02-0487","first-page":"1abs. 5013","article-title":"Phase III randomized trial of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy (RH) versus RH for bulky stage I\/II in cervical cancer (JCOG0102)","volume":"24","author":"Katsumata","year":"2006","journal-title":"Proc Am Soc Clin Oncol"},{"key":"key20180107215713_b27-or-28-02-0487","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ygyno.2007.04.007","article-title":"Treatment of (bulky) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic\/para-aortic lymphadenectomy: a phase III trial of the Gynecologic Oncology Group","volume":"106","author":"Eddy","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180107215713_b28-or-28-02-0487","first-page":"497","article-title":"Follow-up in a long-term randomized trial with neoadjuvant chemotherapy for squamous cell cervical carcinoma","volume":"31","author":"Mossa","year":"2010","journal-title":"Eur J Gynecol Oncol"},{"issue":"1","key":"key20180107215713_b29-or-28-02-0487","first-page":"CD007406","article-title":"Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer","volume":"20","author":"Rydzewska","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180107215713_b30-or-28-02-0487","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/S0959-8049(03)00425-8","article-title":"Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials","volume":"39","author":"Tierney","year":"2003","journal-title":"Eur J Cancer"},{"key":"key20180107215713_b31-or-28-02-0487","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ygyno.2008.05.012","article-title":"The current role of neoadjuvant chemotherapy in the management of cervical carcinoma","volume":"110","author":"Gonzalez-Martin","year":"2008","journal-title":"Gynecol Oncol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.1814\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:57:26Z","timestamp":1515344246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.1814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,5,14]]},"published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.3892\/or.2012.1814"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.1814","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}